We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About AdvanCell Stock

Invest in or calculate the value of your shares in AdvanCell or other pre-IPO companies through EquityZen's platform.

Get Started

AdvanCell Stock

AdvanCell is a clinical-stage radiopharmaceutical company that develops novel cancer therapeutics.

About AdvanCell Stock

Founded

2019

Industries

Software, Artificial Intelligence, Data and Analytics

AdvanCell is a clinical-stage radiopharmaceutical company that develops novel cancer therapeutics. It develops alpha-emitting isotopes attached to molecules that deliver cytotoxic radiation directly to tumors at the molecular level to allow healthcare providers to provide safe and effective treatment for multiple forms of cancer.

AdvanCell Management

Leadership team at AdvanCell

CEO

Andrew Adamovich

Board Member

Anthony Aiudi

Locked Features

Join now and verify your accreditation status to gain access to:

  • AdvanCell Current Valuation
  • AdvanCell Stock Price
  • AdvanCell Management
  • Available deals in AdvanCell and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • AdvanCell Cap Table and Funding History by Share Class and Liquidity Preferences
    • AdvanCell Revenue and Financials
    • AdvanCell Highlights
    • AdvanCell Business Model
    • AdvanCell Risk Factors
  • AdvanCell Research Report from SACRA Research
Join Now

Trading AdvanCell Stock

How to invest in AdvanCell stock?

Accredited investors can buy pre-IPO stock in companies like AdvanCell through EquityZen funds. These investments are made available by existing AdvanCell shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell AdvanCell stock?

Shareholders can sell their AdvanCell stock through EquityZen's private company marketplace. EquityZen's network includes over 350K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 45K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like AdvanCell